DOCSLIB.ORG

Untargeted Metabolomic Profiling in Inborn Errors of Metabolism

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Untargeted Metabolomic Profiling in Inborn Errors of Metabolism testing Untargeted Metabolomic Profiling in Inborn Errors ofprevention Metabolism research V. Reid Sutton, MD education Professor, Molecular & Human Genetics Baylor College of Medicine Medical Director, Biochemical Genetics Laboratory solutions Disclosure A fixed portion of my salary is paid by Baylor Genetics Laboratories but compensation is not tied to laboratory revenue Outline • Common practice and limitations of current routine testing for IEMs • Global Metabolomic Assisted Pathway Screen (Global MAPS®) - Methods • Validation for common IEMs • Confirmation of DNA variant pathogenecity • Discovery of Novel Biomarkers CURRENT RECOMMENDATIONS FOR INTELLECTUAL DISABILITY EVALUATION AAN Recommendations for Intellectual Disability (2011) • Screening for inborn errors of metabolism (IEMs) in children with GDD/ID has a yield of between 0.2% and 4.6%, depending on the presence of clinical indicators and the range of testing performed (Class III). • Testing for congenital disorders of glycosylation has a yield of up to 1.4%, and testing for creatine disorders has a yield of up to 2.8% (Class III). van Karnebeek CDM et al., Mol Genet & Metab 111:428-38, 2014 Current Challenges • For undifferentiated phenotypes, such as intellectual disability, seizures, recurrent vomiting, failure to thrive etc. many different tests are needed • Various fluid types (blood, urine, cerebrospinal fluid) may be needed for diagnosis • Cost for multiple tests may be prohibitive and many are rare, so no good way to tier testing Methods/Tests • HPLC – amino acids • GC/MS – organic acids • MS/MS – Acylcarnitines – Newborn screening – Individual specialized tests • Purines & Pyrimidines • Creatine & guanidinoacetate • Pyridoxine responsive seizure panels • Bile acids • CSF Neurotransmitters • Etc! Rationale for Metabolomic Approach Biochemistry DNA Advantages Any sample type RNA Condensed & information rich Proteins Actionable OH O H O O OH O H HO OH N H OH 2 Biochemicals Bridge between glucose cholesterol threonine genome & phenotype Mechanistic Insight into Phenotype 9 METHODS Metabolon, a global leader in metabolomics Pioneering the emerging field of global biochemical pathway analysis for biomarker discovery and the development of innovative diagnostic tests • Founded in 2000 • Over 150 employees worldwide with expertise in biochemistry, mass spectrometry and software development • 54,000 sq. ft. facility in Research Triangle Park, NC and Sacramento • CLIA-certified lab onsite UHPLC-MS/MS (+ESI) Early/Polar Library Search Biochemical UHPLC-MS/MS (+ESI) Late/Lipid RT, Mass, MS/MS Extraction Data Reduction UHPLC-MS/MS (-ESI) Compound ID QA/QC UHPLC (HILIC)-MS/MS Pathway Visualization: Metabolync™ plugin to Cytoscape developed to Statistical Analysis overlay analyte findings onto metabolic pathways Biomarkers Mechanistic Understanding Drug MoA Interpretation Cellular Characteristics UHPLC-MS/MS (+ESI) Early/Polar Library Search Biochemical UHPLC-MS/MS (+ESI) Late/Lipid RT, Mass, MS/MS Extraction Data Reduction UHPLC-MS/MS (-ESI) Compound ID QA/QC UHPLC (HILIC)-MS/MS Enrich 50-1500 Da small molecule analytes Statistical Analysis Biomarkers Mechanistic Understanding Drug MoA Interpretation Cellular Characteristics UHPLC-MS/MS (+ESI) Early/Polar Library Search Biochemical UHPLC-MS/MS (+ESI) Late/Lipid RT, Mass, MS/MS Extraction Data Reduction UHPLC-MS/MS (-ESI) Compound ID QA/QC UHPLC (HILIC)-MS/MS •Q exactive MS/MS - Orbitrap based MS/MS (Thermo) •Accurate to 1 ppm vs 100 ppm for quadrupole analyzers Statistical Analysis •Cost ~2X quadrupole Biomarkers Mechanistic Understanding Drug MoA Interpretation Cellular Characteristics UHPLC-MS/MS (+ESI) Early/Polar Library Search Biochemical UHPLC-MS/MS (+ESI) Late/Lipid RT, Mass, MS/MS Extraction Data Reduction UHPLC-MS/MS (-ESI) Compound ID QA/QC UHPLC (HILIC)-MS/MS •Library of ~2500 human metabolites Statistical Analysis Biomarkers Mechanistic Understanding Drug MoA Interpretation Cellular Characteristics UHPLC-MS/MS (+ESI) Early/Polar Library Search Biochemical UHPLC-MS/MS (+ESI) Late/Lipid RT, Mass, MS/MS Extraction Data Reduction UHPLC-MS/MS (-ESI) Compound ID QA/QC UHPLC (HILIC)-MS/MS Pathway Visualization: Metabolync™ plugin to Cytoscape developed to Statistical Analysis overlay analyte findings onto metabolic pathways Biomarkers Mechanistic Understanding Drug MoA Interpretation Cellular Characteristics Metabolon’s Approach to Metabolomics - a Comprehensive Survey of the Metabolome 17 Extensive Metabolite Library High resolution biochemistry surveys central metabolism & Baylor Genetics peripheral pathways that 18 drive attributes of phenotype. te a n o r u c u l g - o r d y h e -d P-4 D G e n i m ta u l g isoleucine leucine 2.4.1.18 - -N l y s o b i r o h p s o h -p ' 5 - l y s o b i r o h p s o h -p ' 5 e s o n n a -m -D y x o e -d 6 2.6.1.42 e n i m ta u l g e n i m a s o c u l -g l ty e c -a N 1 2.4.1.1 e n i c u e l o s i o l l -a L valine e d i m a n i c y l g l y m r fo glycineamide te a h p s o h -p 1 e n i m a s o c u l g l ty e c -a P-N D U te a m ta u l g 2.7.7.23 isovalerylalanine ) R A G (F ) R A (G e n i m a l y s o b i r o h p s o h -p 5 2.7.7.44 5.4.2.3 te a r e l a v o s i y x o r d y -h 3 6.3.5.3 2.1.2.2 6.3.4.13 2.4.2.14 3.1.4.3 2.7.7.64 N IO T A L Y S CO Y L G 2.6.1.42 3.1.3.25 5.3.3.- l to i s o n i te a r e l a v o x -o -2 l y th e -m 3 2.6.1.42 1.4.3.2 l to i s o n i l y d ti a h p s o Ph GDE te a h p s o h p o n o -m 2 e n i m a s o c u l g l ty e c -a N 2.6.1.42 l to i s o n -i o y m e s o c u l P-g D U te a n o c a s e m te a n o r u c u l g 1.1.1.271 4.2.1.47 E T RBA CO S A te a h p s o h -p 6 te a r e l a v o s i y x o r d y -h 4 ) te a r a m fu l y th e (m te a h p s o h -p 1 4.6.1.13 2.7.1.64 2.4.1.17 -1 (n n e g o c y l g - l y th e -m 4 SO I Glycogen PP PR M IS L BO A T E M 1.2.1.- te a o r p a c o s i y x o r d y -h a h p l a ? residue) E T A N E H T O T N PA te a r e l a v l y th e -m -3 y x o r d y -h 2 te a r e l a v o x -o 2 te ta o r o ? te a r e l a v o x -o -2 l y th e -m 3 e s o c P-fu D G e s o n n a P-m D G e n i m a s o c u l g l ty e c -a N te a r ty u b o x -o -2 l y th e -m 3 - l y o m a b r a -c N 2.7.1.59 te a r e l a v o s i y x o r d y -h a h p l a ? M) A G (F e n i d i m a n i c y l g l y m r -fo -N l y s o b i r o h p s o h -p ' 5 l to i s o n -i o l l y c s B5) IT (V 3.1.3.25 - -1 l y th e -m 3 te a h p s o h p l y o m a b r a c te ta r a p s a te ta o r o o r d y h i -d 5 , 4 te a m ta u l g l y r e l a v o s i te a n i c c u s l y th e m e n i m ta u l g - -1 l y th e -m 2 PP h -T l ty u b y x o r d y h nd CoA nd a - -1 l y th e -m 2 3.1.3.64 2.7.1.43 A o -C l y r ty u b l y th e -m )-2 (R PP h -T l ty u b y x o r d y h 2.3.1.4 5.1.3.2 glucurono- N E G CO Y L G M IS L BO A T E M PP h -T l y p o r p y x o r d y h -P 4 l to i s o n i e n to c a -l 3 , 6 2.7.7.9 BCKD - 5 , -3 l to i s o n i l y d ti a h p s o h p GTP BCKD 6.3.5.5 2.1.3.2 3.5.2.3 1.3.5.2 3.1.3.64 2.7.1.137 3.1.3.B4 2.7.1.67 2.7.7.13 2.7.7.22 2.4.1.1 BCKD isovaleryglucuronide isovalerylsarcosine 2.7.7.8 e n i e th te n a p , te a h p s o h p i d M IS L BO A T E M te a n e th to n a p 3.5.1.92 6.3.3.1 l to i s o n i T PG F e s to c a l a P-g D U 1.3.99.- te a n o r u c u l g 2.7.7.12 - S-(2 )P2 5 , (3 PI 1.13.99.1 3.1.1.19 )- l y o n ta u b l y th e -m S-(2 )- l y o n ta u b l y th e -m S-(3 te a h p s o h p s i -b 3 , 1 te a h p s o h -p -6 e n i m a s o c u l g 2.7.1.1 glucosamine 2.4.1.1 n i tr x e d to l a m te a l y d ti o r o 2.4.2.10 glucose ) l y n o i p o r p l y th e dihydrolipoamide -E e d i m a o p i l o r d y h i d ) l y d i r -u ' (5 s i -B P4 , P1 ) (n te a o n ta p e h o s i y x o r d y -h 3 te a h p s o h -p 1 -E e d i m a o p i l o r d y h i -d te a h p s o h -p -1 e s o n n a m te a h p s o h p a tr te 3.1.3.57 2.7.1.33 ROS 3.6.1.19 te a h p s o h -p -1 e s o c fu A o -C l y l y r c a l y th -e 2 te a r ty u b l y th e -m 2 3.1.2.20 A o -C l y r ty u b l y th e -m 2 te a r e l a v o s i e s to c a l a g te a r ty u b o s i A o -C l y r ty u b o s I A o -C l y r e l a v o s i 3.1.2.20 3.1.2.20 5.3.3.- 4.1.1.23 1.1.1.19 te a h p s o h -p 1 e s o a x e h to l a m 2.7.7.10 3.6.1.17 1.2.1.3 2.7.1.48 2.7.4.6 3.5.99.6 2.6.1.16 2.7.4.14 )P (3 PI )P (4 PI 2.7.1.150 l to i s o n i e n i th te n a p e l zo a d i m i o n i m -a -5 l y x o b i r o h p s o h p ' 5 5.4.2.2 5.4.2.8 2.4.1.1 uracil MP U UDP UTP RNA te a h p s o h p s i -b 4 , 1 te a n e th to n a p o h p s o h -p ' 4 4.2.1.17 ) R I (A 2.4.2.3 uridine 3.1.3.5 3.6.1.6 2.7.4.10 2.7.7.6 L O IT S O IN 2.7.1.52 te a n o l u g E S O CT A L A G 3.6.1.5 3.6.1.5 M IS L BO A T E M e s o ta n e p to l a m e n i te s y c 2.4.2.9 5.3.1.8 2.7.1.6 e s o c fu te a h p s o h -p -6 e s o n n a m te a h p s o h -p -6 e s to c u fr M IS L BO A T E M 2.3.1.7 1.3.8.1 1.3.99.12 1.3.99.- 1.3.8.7 2.3.1.13 2.3.1.13 1.3.8.7 1.3.99.12 1.3.8.1 2.3.1.7 1.3.8.7 1.3.8.4 2.3.1.13 2.3.1.7 1.3.1.2 e s to a g ta A o -C l y y r c a r d y h l y th -e 2 ET I D / T U G 2.7.1.33 l o r e c y l g l y to i m l a p i -d 2 , 1 te a r ta c a l a g 6.3.2.5 3.5.4.5 6.3.4.2 2.4.1.1 2.7.4.68 ) d i c a c i c u (m 3.1.3.66 2.7.1.154 2.7.1.154 3.1.3.36 3.1.1.25 3.1.1.17 3.1.3.56 e s to c a l a g 3.2.1.23 e s to c a l 4.1.1.21 2.7.1.48 2.7.4.14 2.7.4.6 2.7.1.7 2.7.1.1 3.1.2.4 te a r ta c a l a g e s o a tr te to l a m l to ti c a l a g e n i c y l g l y r ty u b l y th e -m 2 e n ti i n r a c l y r ty u b l y th e -m 2 CTP ) d i c a c i c u (m 2.7.1.1 ) l to i c l u (d e n i d ti y c MP -C ' 5 CDP 2.7.1.159 2.7.1.127 1.1.1.21 ) 5 (C e n to c a -l 4 , -1 o n o l u g mannose
Load more

Recommended publications
  • Neurotransmitter Resource Guide
    NEUROTRANSMITTER RESOURCE GUIDE Science + Insight doctorsdata.com Doctor’s Data, Inc. Neurotransmitter RESOURCE GUIDE Table of Contents Sample Report Sample Report ........................................................................................................................................................................... 1 Analyte Considerations Phenylethylamine (B-phenylethylamine or PEA) ................................................................................................. 1 Tyrosine .......................................................................................................................................................................................... 3 Tyramine ........................................................................................................................................................................................4 Dopamine .....................................................................................................................................................................................6 3, 4-Dihydroxyphenylacetic Acid (DOPAC) ............................................................................................................... 7 3-Methoxytyramine (3-MT) ............................................................................................................................................... 9 Norepinephrine ........................................................................................................................................................................
    [Show full text]
  • Hyperammonemia in Review: Pathophysiology, Diagnosis, and Treatment
    Pediatr Nephrol DOI 10.1007/s00467-011-1838-5 EDUCATIONAL REVIEW Hyperammonemia in review: pathophysiology, diagnosis, and treatment Ari Auron & Patrick D. Brophy Received: 23 September 2010 /Revised: 9 January 2011 /Accepted: 12 January 2011 # IPNA 2011 Abstract Ammonia is an important source of nitrogen and is the breakdown and catabolism of dietary and bodily proteins, required for amino acid synthesis. It is also necessary for respectively. In healthy individuals, amino acids that are not normal acid-base balance. When present in high concentra- needed for protein synthesis are metabolized in various tions, ammonia is toxic. Endogenous ammonia intoxication chemical pathways, with the rest of the nitrogen waste being can occur when there is impaired capacity of the body to converted to urea. Ammonia is important for normal animal excrete nitrogenous waste, as seen with congenital enzymatic acid-base balance. During exercise, ammonia is produced in deficiencies. A variety of environmental causes and medica- skeletal muscle from deamination of adenosine monophos- tions may also lead to ammonia toxicity. Hyperammonemia phate and amino acid catabolism. In the brain, the latter refers to a clinical condition associated with elevated processes plus the activity of glutamate dehydrogenase ammonia levels manifested by a variety of symptoms and mediate ammonia production. After formation of ammonium signs, including significant central nervous system (CNS) from glutamine, α-ketoglutarate, a byproduct, may be abnormalities. Appropriate and timely management requires a degraded to produce two molecules of bicarbonate, which solid understanding of the fundamental pathophysiology, are then available to buffer acids produced by dietary sources. differential diagnosis, and treatment approaches available.
    [Show full text]
  • Dehydroepiandrosterone Sulfate (DHEAS) Stimulates the First Step in the Biosynthesis of Steroid Hormones
    Dehydroepiandrosterone Sulfate (DHEAS) Stimulates the First Step in the Biosynthesis of Steroid Hormones Jens Neunzig, Rita Bernhardt* Department of Biochemistry, Faculty of Technical and Natural Sciences III, Saarland University, Saarbru¨cken, Germany Abstract Dehydroepiandrosterone sulfate (DHEAS) is the most abundant circulating steroid in human, with the highest concentrations between age 20 and 30, but displaying a significant decrease with age. Many beneficial functions are ascribed to DHEAS. Nevertheless, long-term studies are very scarce concerning the intake of DHEAS over several years, and molecular investigations on DHEAS action are missing so far. In this study, the role of DHEAS on the first and rate-limiting step of steroid hormone biosynthesis was analyzed in a reconstituted in vitro system, consisting of purified CYP11A1, adrenodoxin and adrenodoxin reductase. DHEAS enhances the conversion of cholesterol by 26%. Detailed analyses of the mechanism of DHEAS action revealed increased binding affinity of cholesterol to CYP11A1 and enforced interaction with the electron transfer partner, adrenodoxin. Difference spectroscopy showed Kd-values of 4062.7 mM and 24.860.5 mM for CYP11A1 and cholesterol without and with addition of DHEAS, respectively. To determine the Kd-value for CYP11A1 and adrenodoxin, surface plasmon resonance measurements were performed, demonstrating a Kd-value of 3.060.35 nM (with cholesterol) and of 2.460.05 nM when cholesterol and DHEAS were added. Kinetic experiments showed a lower Km and a higher kcat value for CYP11A1 in the presence of DHEAS leading to an increase of the catalytic efficiency by 75%. These findings indicate that DHEAS affects steroid hormone biosynthesis on a molecular level resulting in an increased formation of pregnenolone.
    [Show full text]
  • Research Collection
    Research Collection Doctoral Thesis Some reactions in the D-ring of the steroids Author(s): Boyce, Sam Framroze Publication Date: 1958 Permanent Link: https://doi.org/10.3929/ethz-a-000089222 Rights / License: In Copyright - Non-Commercial Use Permitted This page was generated automatically upon download from the ETH Zurich Research Collection. For more information please consult the Terms of use. ETH Library Prom. Nr. 2111 SOME REACTIONS IN THE D-RING 0! THE STEROIDS Thesis presented to The Swiss Federal Institute of Technology Zurich for the Degree of Doctor of Technical Science by SAM FRAMROZE BOYCE Indian Citizen Accepted on the recommendation of Prof. Dr. L. Ruzicka Priv. Doz. Dr. H. Heusser The Commercial Printing Press Private Ltd., Bombay 1958 TO THE MEMORY OF MY DEAR PARENTS ACKNOWLEDGEMENTS For giving me the opportunity to carry out this work, for his encouragement and keen interest during its progress, I here express my deep gratitude to Prof. L. Ruzicka. I am also indebted to Prof. L. Ruzicka and Prof. PI. A. Plattner for guidance of this work. My sincere thanks are also due to P. D. Dr. H. Heussor for his continued co-operation and helpful suggestions during the course of this work. To Prof. V. Prelog, I am obliged for the valuable discussions and critical comments. Finally, I am indebted to Prof. M. Giinthard for the infra-red spectra and to Mr. W. Manser for the micro-analysis. m CONTENTS GENERAL INTRODUCTION 1 Pabt I REARRANGEMENT OF a-HALOGENO-20-KETOSTEROIDS Theoretical Part 3 Experimental Part 10 Pabt Ha BASE CATALYSED REACTIONS WITH A16-3 jS-ACETOXY- 14,15 0-EPOXY-5-ALLOETIOCHOLENIC ACID METHYL ESTER Theoretical Part 18 Experimental Part 27 Pabt lib BASE AND ACID CATALYSED REACTIONS WITH A16-3j3- ACETOXY-14,15/3-EPOXY-20-KETO-5-ALLOPREGNENE Theoretical Part ..
    [Show full text]
  • Excretion Patterns of Fecal Progestagens, Androgen and Estrogens During Pregnancy, Parturition and Postpartum in Okapi (Okapia Johnstoni)
    Journal of Reproduction and Development, Vol. 53, No. 1, 2007 —Research Note— Excretion Patterns of Fecal Progestagens, Androgen and Estrogens During Pregnancy, Parturition and Postpartum in Okapi (Okapia johnstoni) Satoshi KUSUDA1), Koki MORIKAKU2), Ken-ichi KAWADA3), Kenji ISHIWADA4)# and Osamu DOI3) 1)Laboratory of Animal Reproduction, United Graduate School of Agricultural Science, Gifu University, Gifu 501-1193, 2)Preservation and Research Center, City of Yokohama, Kanagawa 241-0804, 3)Laboratory of Animal Reproduction, Faculty of Applied Biological Sciences, Gifu University, Gifu 501-1193 and 4)Yokohama Zoological Gardens Zoorasia, Kanagawa 241- 0001, Japan #Present: Kanazawa Zoological Gardens of Yokohama, Kanagawa 236-0042, Japan Abstract. The aim of the present study was to establish a simple method to monitor ovarian activity and non-invasively diagnose pregnancy in okapi (Okapia johnstoni). The feces of a female okapi were collected daily or every 3 days for 28 months. Steroids in lyophilized feces were extracted with 80% methanol, and the fecal levels of immunoreactive progestagens (progesterone and pregnanediol- glucuronide), androgen (testosterone), and estrogens (estradiol-17β and estrone) were determined by enzyme immunoassays with commercially available antisera. Using the progesterone profiles, the durations of the luteal phase, follicular phase, and estrous cycle were determined to be 11.1 ± 0.4, 5.3 ± 0.6, and 16.5 ± 0.7 days (n=22), respectively. Fecal levels of immunoreactive progesterone, pregnanediol glucuronide, and testosterone gradually increased from early pregnancy and peaked several months before parturition. More pregnanediol glucuronide was excreted in feces than progesterone during late pregnancy, but not during the estrous cycle. Although the fecal concentrations of immunoreactive estradiol-17β and estrone change a little throughout pregnancy and non-pregnancy, they rose sharply and temporarily on the day following parturition.
    [Show full text]
  • Clinical Spectrum of Glycine Encephalopathy in Indian Children
    Clinical Spectrum of Glycine Encephalopathy in Indian children Anil B. Jalan *, Nandan Yardi ** NIRMAN, 203, Nirman Vyapar Kendra, Sector 17, Vashi – Navi-Mumbai, India – 400 705 * Chief Scientific Research Officer (Bio – chemical Genetics) ** Paediatric Neurologist an Epileptologist, Pune. Introduction: NKH is generally considered to be a rare disease, but relatively higher incidences have been reported in Northern Finland, British Columbia and Israel (1,2). Non Ketotic Hyperglycinemia, also known as Glycine Encephalopathy, is an Autosomal recessive disorder of Glycine metabolism caused by a defect in the Glycine cleavage enzyme complex (GCS). GCS is a complex of four proteins and coded on 4 different chromosomes. 1. P – Protein ( Pyridoxal Phosphate containing glycine Decarboxylase, GLDC) -> 80 % cases, [ MIM no. 238300 ] , 2. H – Protein (Lipoic acid containing) – Rare, [MIM no. 238310], 3. T – Protein ( Tetrahydrofolate requiring aminomethyltranferase AMT ) – 15 % cases [ MIM no. 238330], 4. L – Protein (Lipoamide dehydrogenase) – MSUD like picture [MIM no. 238331] (1). In classical NKH, levels of CSF – glycine and the ratio of CSF / Plasma glycine are very high (1). Classically, NKH presents in the early neonatal period with progressive lethargy, hypotonia, myoclonic jerks, hiccups, and apnea, usually leading to total unresponsiveness, coma, and death unless the patient is supported through this stage with mechanical ventilation. Survivors almost invariably display profound neurological disability and intractable seizures. In a minority of NKH cases the presentation is atypical with a later onset and features including seizures, developmental delay and / or regression, hyperactivity, spastic diplegia, spino – cerebeller degeneration, optic atrophy, vertical gaze palsy, ataxia, chorea, and pulmonary hypertension. Atypical cases are more likely to have milder elevations of glycine concentrations (2).
    [Show full text]
  • 01 Front.Pdf
    Copyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and private study only. The thesis may not be reproduced elsewhere without the permission of the Author. STUDIES TOWARDS THE DEVELOPMENT OF A MULTI­ PURPOSE HOME SELF-TEST KIT FOR THE DETECTION OF URINARY TETRAHYDROCORTISONE AND TESTOSTERONE METABOLITES A thesis submitted in partial fulfilment of the requirements for the degree of Master of Science in Chemistry at Massey University Claire Margaret Nielsen 2003 ii Abstract The development of homogeneous enzyme immunoassays (HEIA) for testosterone glucuronide (TG) and tetrahydrocortisone glucuronide (THEG) in urine are described. The proposed test system is based on the Ovarian Monitor homogeneous immunoassay system, established by J.B Brown and L.F. Blackwell et al. 1 as a simple, laboratory accurate, monitoring device for the measurement of estrone glucuronide (E1G) and pregnanediol glucuronide (PdG) as markers of the fertile phase during a womans menstrual cycle. This information can be used readily by women to identify their cyclical periods of fertility and infertility. The major testosterone metabolite in the urine of males, testosterone p-glucuronide, was synthesised by firstly preparing the glycosyl donor a-bromosugar and conjugating this with testosterone under standard Koenigs-Knorr conditions. 1H nmr studies confirmed that the synthetic steroid glucuronide had the same stereochemistry as the naturally occurring urinary testosterone glucuronide. Testosterone glucuronide and tetrahydrocortisone glucuronide conjugates of hen egg white lysozyme were prepared using the active ester coupling method in good yield. Unreacted lysozyme was successfully removed from the reaction mixture by a combination of cation­ exchange chromatography in 7 M urea and hydrophobic-interaction chromatography.
    [Show full text]
  • Hyperbilirubinemia
    Porphyrins Porphyrins (Porphins) are cyclic tetrapyrol compounds formed by the linkage )). of four pyrrole rings through methenyl bridges (( HC In the reduced porphyrins (Porphyrinogens) the linkage of four pyrrole rings (tetrapyrol) through methylene bridges (( CH2 )) The characteristic property of porphyrins is the formation of complexes with the metal ion bound to nitrogen atoms of the pyrrole rings. e.g. Heme (iron porphyrin). Proteins which contain heme ((hemoproteins)) are widely distributed e.g. Hemoglobin, Myoglobin, Cytochromes, Catalase & Tryptophan pyrrolase. Natural porphyrins have substituent side chains on the eight hydrogen atoms numbered on the pyrrole rings. These side chains are: CH 1-Methyl-group (M)… (( 3 )) 2-Acetate-group (A)… (( CH2COOH )) 3-Propionate-group (P)… (( CH2CH2COOH )) 4-Vinyl-group (V)… (( CH CH2 )) Porphyrins with asymmetric arrangement of the side chains are classified as type III porphyrins while those with symmetric arrangement of the side chains are classified as type I porphyrins. Only types I & III are present in nature & type III series is more important because it includes heme. 1 Heme Biosynthesis Heme biosynthesis occurs through the following steps: 1-The starting reaction is the condensation between succinyl-CoA ((derived from citric acid cycle in the mitochondria)) & glycine, this reaction is a rate limiting reaction in the hepatic heme synthesis, it occurs in the mitochondria & is catalyzed by ALA synthase (Aminolevulinate synthase) enzyme in the presence of pyridoxal phosphate as a cofactor. The product of this reaction is α-amino-β-ketoadipate which is rapidly decarboxylated to form δ-aminolevulinate (ALA). 2-In the cytoplasm condensation reaction between two molecules of ALA is catalyzed by ALA dehydratase enzyme to form two molecules of water & one 2 molecule of porphobilinogen (PBG) which is a precursor of pyrrole.
    [Show full text]
  • Characterisation of Bilirubin Metabolic Pathway in Hepatic Mitochondria Siti Nur Fadzilah Muhsain M.Sc
    Characterisation of Bilirubin Metabolic Pathway in Hepatic Mitochondria Siti Nur Fadzilah Muhsain M.Sc. (Medical Research) 2005 Universiti Sains Malaysia Postgrad. Dip. (Toxicology) 2003 University of Surrey B.Sc.(Biomed. Sc.) 2000 Universiti Putra Malaysia A thesis submitted for the degree of Doctor of Philosophy at The University of Queensland in 2014 School of Medicine ABSTRACT Bilirubin (BR), a toxic waste product of degraded haem, is a potent antioxidant at physiological concentrations. To achieve the maximum benefit of BR, its intracellular level needs to be carefully regulated. A system comprising of two enzymes, haem oxygenase-1 (HMOX1) and cytochrome P450 2A5 (CYP2A5) exists in the endoplasmic reticulum (ER), responsible for regulating BR homeostasis. This system is induced in response to oxidative stress. In this thesis, oxidative stress caused accumulation of these enzymes in mitochondria — major producers and targets of reactive oxygen species (ROS) — is demonstrated. To understand the significance of this intracellular targeting, properties of microsomal and mitochondrial BR metabolising enzymes were compared and the capacity of mitochondrial CYP2A5 to oxidise BR in response to oxidative stress is reported. Microsomes and mitochondrial fractions were isolated from liver homogenates of DBA/2J mice, administered with sub-toxic dose of pyrazole, an oxidant stressor. The purity of extracted organelles was determined by analysing the expressions and activities of their respective marker enzymes. HMOX1 and CYP2A5 were significantly increased in microsomes and even more so in mitochondria in response to pyrazole-induced oxidative stress. By contrast, the treatment did not increase either microsomes or mitochondrial Uridine-diphosphate-glucuronosyltransferase 1A1 (UGT1A1), the sole enzyme that catalyses BR elimination through glucuronidation.
    [Show full text]
  • Steroid Profiling in Urine of Intact Glucuronidated and Sulfated
    CORE Metadata, citation and similar papers at core.ac.uk Provided by Ghent University Academic Bibliography Journal of Chromatography A 1624 (2020) 461231 Contents lists available at ScienceDirect Journal of Chromatography A journal homepage: www.elsevier.com/locate/chroma Steroid profiling in urine of intact glucuronidated and sulfated steroids using liquid chromatography-mass spectrometry ∗ Laurie De Wilde , Kris Roels, Pieter Van Renterghem, Peter Van Eenoo, Koen Deventer 1 Doping Control Laboratory (DoCoLab), Ghent University (UGent), Department Diagnostic Sciences, Technologiepark 30B, B-9052 Zwijnaarde, Belgium a r t i c l e i n f o a b s t r a c t Article history: Detection of endogenous anabolic androgenic steroids (EAAS) misuse is a major challenge in doping con- Received 26 November 2019 trol analysis. Currently, a number of endogenous steroids, which constitute the steroid profile, are quanti- Revised 6 May 2020 fied using gas chromatography (GC). With this methodology, only the sum of the free and glucuronidated Accepted 10 May 2020 steroids is measured together. A dilute-and-shoot LC-MS method, which is compliant with the quality Available online 23 May 2020 requirements for measuring EAAS established by the World Anti-Doping Agency (WADA), was devel- Keywords: oped and validated containing glucuronidated and sulfated steroids in order to gain some extra infor- Doping mation and to expand the existing steroid profile. The developed method is, to the best of our knowl- Urine edge, the first method to combine both steroid glucuronides and sulfates, which is compliant with the Steroid profile quality standards of the technical document on EAAS, established by WADA.
    [Show full text]
  • Identification of Human Sulfotransferases Involved in Lorcaserin N-Sulfamate Formation
    1521-009X/44/4/570–575$25.00 http://dx.doi.org/10.1124/dmd.115.067397 DRUG METABOLISM AND DISPOSITION Drug Metab Dispos 44:570–575, April 2016 Copyright ª 2016 by The American Society for Pharmacology and Experimental Therapeutics Identification of Human Sulfotransferases Involved in Lorcaserin N-Sulfamate Formation Abu J. M. Sadeque, Safet Palamar,1 Khawja A. Usmani, Chuan Chen, Matthew A. Cerny,2 and Weichao G. Chen3 Department of Drug Metabolism and Pharmacokinetics, Arena Pharmaceuticals, Inc., San Diego, California Received September 30, 2015; accepted January 7, 2016 ABSTRACT Lorcaserin [(R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benza- and among the SULT isoforms SULT1A1 was the most efficient. The zepine] hydrochloride hemihydrate, a selective serotonin 5-hydroxy- order of intrinsic clearance for lorcaserin N-sulfamate is SULT1A1 > Downloaded from tryptamine (5-HT) 5-HT2C receptor agonist, is approved by the U.S. SULT2A1 > SULT1A2 > SULT1E1. Inhibitory effects of lorcaserin Food and Drug Administration for chronic weight management. N-sulfamate on major human cytochrome P450 (P450) enzymes Lorcaserin is primarily cleared by metabolism, which involves were not observed or minimal. Lorcaserin N-sulfamate binds to multiple enzyme systems with various metabolic pathways in human plasma protein with high affinity (i.e., >99%). Thus, despite humans. The major circulating metabolite is lorcaserin N-sulfamate. being the major circulating metabolite, the level of free lorcaserin Both human liver and renal cytosols catalyze the formation of N-sulfamate would be minimal at a lorcaserin therapeutic dose and lorcaserin N-sulfamate, where the liver cytosol showed a higher unlikely be sufficient to cause drug-drug interactions.
    [Show full text]
  • Xerox University Microfilms
    INFORMATION TO USERS This material was produced from a microfilm copy of the original document. While the most advanced technological means to photograph and reproduce this document have been used, the quality is heavily dependent upon the quality of the original submitted. The following explanation of techniques is provided to help you understand markings or patterns which may appear on this reproduction. 1.The sign or "target" for pages apparently lacking from the document photographed is "Missing Page(s)". If it was possible to obtain the missing page{s) or section, they are spliced into the film along with adjacent pages. This may have necessitated cutting thru an image and duplicating adjacent pages to insure you complete continuity. 2. When an image on the film is obliterated with a large round black mark, it is an indication that the photographer suspected that the copy may have moved during exposure and thus cause a blurred image. You will find a good image of the page in the adjacent frame. 3. When a map, drawing or chart, etc., was part of the material being photographed the photographer followed a definite method in "sectioning" the material. It is customary to begin photoing at the upper left hand corner of a large sheet and to continue photoing from left to right in equal sections with a small overlap. If necessary, sectioning is continued again — beginning below the first row and continuing on until complete. 4. The majority of users indicate that the textual content is of greatest value, however, a somewhat higher quality reproduction could be made from "photographs" if essential to the understanding of the dissertation.
    [Show full text]